Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mahuang Tang is a traditional Chinese herbal prescription (THP) that has been used for centuries, originating around 220 AD. It is primarily known for its ability to induce perspiration to relieve exterior pathogenic factors, disperse and open the Lung to relieve asthma and wheezing, and stop coughing, particularly for exterior syndrome due to Wind-Cold. Research indicates it possesses vasorelaxant activities on isolated rat aortic rings. Furthermore, it has demonstrated antiviral effects against influenza A/H1N1 virus in vitro by blocking viral entry into host cells, inhibiting viral biosynthesis, and downregulating the mRNA expression of TLR4, TLR7, MyD88, and TRAF6. The formula is composed of several herbs, including Ma Huang (Ephedra sinica), Gui Zhi (Cinnamon twig), Xing Ren (Apricot kernel), and Zhi Gan Cao (Honey-fried licorice).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mahuang Tang.